This Interactive panel discussion featuring leaders from across the life sciences industry will discuss emerging trends in the use of RWE, challenges in realizing the full potential, technology trends and strategic investments.
- Jeffrey Morgan, Managing Director, Life Sciences, Deloitte
- Nirosha Mahendraratnam Lederer, PhD, MSPH, Managing Associate, Real World Evidence, Duke-Margolis Center for Health Policy, Duke University
- Christopher P. Boone, PhD, FACHE, FHIMSS, Vice President, Global Head of Health Economics and Outcomes Research, AbbVie
- Patrick Loerch, Senior Vice President, Data Science and Biometrics, Gilead